| 摘要 |
A pharmaceutical composition comprised of Taxol3, Taxotere3, or derivatives and a cyclin-dependent kinase is described, as well as a form of administration wherein the taxane is given intermittently and the cyclin-dependent kinase is given repeatedly within the same cycle. |
